In plain terms: the engine's documented pattern that, once product-liability is severed from product-profit, the barrier-to-entry for adding new products to a captive market collapses asymmetrically. Canonical instance: 1986 NCVIA removed vaccine-manufacturer liability via VICP no-fault federal program funded by per-dose excise tax (consumer pays for own injury compensation). 1980 childhood schedule = 23 doses / 7 diseases. 2024 schedule = 84-88 doses / 18 diseases. American children now receive ~2x doses of comparable European nations. Pattern recognition: look for liability-shield architectures in adjacent emerging product categories (mRNA platforms beyond vaccines, gene-therapy, AI medical-device approvals via FDA's 510(k) pathway, autonomous-vehicle product liability frameworks). When liability is severed without independent placebo-controlled trial requirement + meaningful injury reporting + real discovery rights, schedule expansion is structurally guaranteed.